Psychiatric Co-morbidity in Ketamine and Methamphetamine Dependence: a Retrospective Chart Review

Wai Kwong Tang, Huajun Liang, Yong Lin, Chenxi Zhang, Alan Tang, Fu Chan, Tom P. Freeman, Gabor S. Ungvari

Research output: Contribution to journalArticle

Abstract

Both ketamine and methamphetamine (MA) have become very popular and have been abused worldwide over the past two decades. However, the relationship between dependence on ketamine or MA and psychiatric comorbidities is still unclear. This study aimed to examine the frequency of co-morbid psychiatric disorders in patients dependent on ketamine or methamphetamine who were receiving treatment at three substance abuse treatment clinics (SACs) in Hong Kong. This was a retrospective chart review. The medical records of 183 patients (103 with ketamine and 80 with MA dependence) treated between January 2008 and August 2012 were retrieved. Patients’ demographic data, patterns of substance abuse and comorbid psychiatric diagnoses were recorded. The mean age of onset and duration of substance abuse were 18.1 ± 4.7 and 9.2 ± 6.2 years for ketamine and 19.9 ± 8.8 and 10.5 ± 9.8 years for MA users, respectively. Psychotic disorders were more common in MA dependent users (76.2 % vs. 28.2 %, p < 0.001), whereas mood disorders were more common in ketamine dependent users (27.2 % vs. 11.2 %, p = 0.008). Ketamine and MA dependence have a notably different profile of psychiatric co-morbidity. Compared with MA dependence, ketamine dependence is more likely to be associated with mood disorders and less likely with psychotic disorders.

LanguageEnglish
Pages956-966
Number of pages11
JournalInternational Journal of Mental Health and Addiction
Volume15
Issue number4
Early online date3 Oct 2016
DOIs
StatusPublished - 1 Aug 2017

Fingerprint

Methamphetamine
Ketamine
Psychiatry
Morbidity
Substance-Related Disorders
Mood Disorders
Psychotic Disorders
Hong Kong
Age of Onset
Mental Disorders
Medical Records
Comorbidity
Demography
Therapeutics

Keywords

  • Co-morbidity
  • Ketamine
  • Methamphetamine
  • Mood disorders
  • Psychotic disorders

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Psychiatric Co-morbidity in Ketamine and Methamphetamine Dependence : a Retrospective Chart Review. / Tang, Wai Kwong; Liang, Huajun; Lin, Yong; Zhang, Chenxi; Tang, Alan; Chan, Fu; Freeman, Tom P.; Ungvari, Gabor S.

In: International Journal of Mental Health and Addiction, Vol. 15, No. 4, 01.08.2017, p. 956-966.

Research output: Contribution to journalArticle

Tang, Wai Kwong ; Liang, Huajun ; Lin, Yong ; Zhang, Chenxi ; Tang, Alan ; Chan, Fu ; Freeman, Tom P. ; Ungvari, Gabor S. / Psychiatric Co-morbidity in Ketamine and Methamphetamine Dependence : a Retrospective Chart Review. In: International Journal of Mental Health and Addiction. 2017 ; Vol. 15, No. 4. pp. 956-966.
@article{ab5531e581e24dc18731786cd1a34b81,
title = "Psychiatric Co-morbidity in Ketamine and Methamphetamine Dependence: a Retrospective Chart Review",
abstract = "Both ketamine and methamphetamine (MA) have become very popular and have been abused worldwide over the past two decades. However, the relationship between dependence on ketamine or MA and psychiatric comorbidities is still unclear. This study aimed to examine the frequency of co-morbid psychiatric disorders in patients dependent on ketamine or methamphetamine who were receiving treatment at three substance abuse treatment clinics (SACs) in Hong Kong. This was a retrospective chart review. The medical records of 183 patients (103 with ketamine and 80 with MA dependence) treated between January 2008 and August 2012 were retrieved. Patients’ demographic data, patterns of substance abuse and comorbid psychiatric diagnoses were recorded. The mean age of onset and duration of substance abuse were 18.1 ± 4.7 and 9.2 ± 6.2 years for ketamine and 19.9 ± 8.8 and 10.5 ± 9.8 years for MA users, respectively. Psychotic disorders were more common in MA dependent users (76.2 {\%} vs. 28.2 {\%}, p < 0.001), whereas mood disorders were more common in ketamine dependent users (27.2 {\%} vs. 11.2 {\%}, p = 0.008). Ketamine and MA dependence have a notably different profile of psychiatric co-morbidity. Compared with MA dependence, ketamine dependence is more likely to be associated with mood disorders and less likely with psychotic disorders.",
keywords = "Co-morbidity, Ketamine, Methamphetamine, Mood disorders, Psychotic disorders",
author = "Tang, {Wai Kwong} and Huajun Liang and Yong Lin and Chenxi Zhang and Alan Tang and Fu Chan and Freeman, {Tom P.} and Ungvari, {Gabor S.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1007/s11469-016-9681-3",
language = "English",
volume = "15",
pages = "956--966",
journal = "International Journal of Mental Health and Addiction",
issn = "1557-1874",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Psychiatric Co-morbidity in Ketamine and Methamphetamine Dependence

T2 - International Journal of Mental Health and Addiction

AU - Tang, Wai Kwong

AU - Liang, Huajun

AU - Lin, Yong

AU - Zhang, Chenxi

AU - Tang, Alan

AU - Chan, Fu

AU - Freeman, Tom P.

AU - Ungvari, Gabor S.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Both ketamine and methamphetamine (MA) have become very popular and have been abused worldwide over the past two decades. However, the relationship between dependence on ketamine or MA and psychiatric comorbidities is still unclear. This study aimed to examine the frequency of co-morbid psychiatric disorders in patients dependent on ketamine or methamphetamine who were receiving treatment at three substance abuse treatment clinics (SACs) in Hong Kong. This was a retrospective chart review. The medical records of 183 patients (103 with ketamine and 80 with MA dependence) treated between January 2008 and August 2012 were retrieved. Patients’ demographic data, patterns of substance abuse and comorbid psychiatric diagnoses were recorded. The mean age of onset and duration of substance abuse were 18.1 ± 4.7 and 9.2 ± 6.2 years for ketamine and 19.9 ± 8.8 and 10.5 ± 9.8 years for MA users, respectively. Psychotic disorders were more common in MA dependent users (76.2 % vs. 28.2 %, p < 0.001), whereas mood disorders were more common in ketamine dependent users (27.2 % vs. 11.2 %, p = 0.008). Ketamine and MA dependence have a notably different profile of psychiatric co-morbidity. Compared with MA dependence, ketamine dependence is more likely to be associated with mood disorders and less likely with psychotic disorders.

AB - Both ketamine and methamphetamine (MA) have become very popular and have been abused worldwide over the past two decades. However, the relationship between dependence on ketamine or MA and psychiatric comorbidities is still unclear. This study aimed to examine the frequency of co-morbid psychiatric disorders in patients dependent on ketamine or methamphetamine who were receiving treatment at three substance abuse treatment clinics (SACs) in Hong Kong. This was a retrospective chart review. The medical records of 183 patients (103 with ketamine and 80 with MA dependence) treated between January 2008 and August 2012 were retrieved. Patients’ demographic data, patterns of substance abuse and comorbid psychiatric diagnoses were recorded. The mean age of onset and duration of substance abuse were 18.1 ± 4.7 and 9.2 ± 6.2 years for ketamine and 19.9 ± 8.8 and 10.5 ± 9.8 years for MA users, respectively. Psychotic disorders were more common in MA dependent users (76.2 % vs. 28.2 %, p < 0.001), whereas mood disorders were more common in ketamine dependent users (27.2 % vs. 11.2 %, p = 0.008). Ketamine and MA dependence have a notably different profile of psychiatric co-morbidity. Compared with MA dependence, ketamine dependence is more likely to be associated with mood disorders and less likely with psychotic disorders.

KW - Co-morbidity

KW - Ketamine

KW - Methamphetamine

KW - Mood disorders

KW - Psychotic disorders

UR - http://www.scopus.com/inward/record.url?scp=84989921738&partnerID=8YFLogxK

U2 - 10.1007/s11469-016-9681-3

DO - 10.1007/s11469-016-9681-3

M3 - Article

VL - 15

SP - 956

EP - 966

JO - International Journal of Mental Health and Addiction

JF - International Journal of Mental Health and Addiction

SN - 1557-1874

IS - 4

ER -